Send to

Choose Destination
Clin Biochem. 2007 Mar;40(5-6):326-9. Epub 2007 Jan 5.

Elevated C-reactive protein in acute coronary syndrome presentation is an independent predictor of long-term mortality and heart failure.

Author information

Department of Pathology and Molecular Medicine, McMaster University, 1200 Main St. W., HSC 2N52, Hamilton, ON, Canada L8N 3Z5.



To assess the ability of C-reactive protein (CRP) to predict long-term outcomes in a chest pain population.


CRP was measured at presentation in 446 emergency department patients with acute coronary syndromes. All-cause mortality and hospital discharges for acute myocardial infarction (AMI) and congestive heart failure (CHF) were obtained for up to 8 years following the event.


Kaplan-Meier analyses indicated that patients with CRP concentrations above the American Heart Association scientific statement cut-off had a higher rate for death and CHF admissions. After adjusting for troponin concentrations, in a Cox proportional hazard model, only CRP concentrations indicative of an acute phase response (i.e., >7.44 mg/L) were associated with a significant risk for death after 5 years and CHF readmission after 2 years.


Patients presenting early with chest pain with elevated CRP concentrations have a greater long-term risk for death and heart failure.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center